Key facts
- Heart Rhythm Society (HRS) and Milestone Pharmaceuticals are partnering.
- The partnership aims to expand patient education for supraventricular tachycardia (SVT).
- New resources will be available through UpBeat.org.
- The initiative is launched in recognition of SVT Awareness Day.
This partnership between the Heart Rhythm Society and Milestone Pharmaceuticals focuses on increasing awareness and providing resources for individuals with supraventricular tachycardia (SVT). By leveraging the platform UpBeat.org, the collaboration aims to reach more patients and offer them valuable information and support regarding their condition.